Table of Content




1. Executive Summary


2. Global Parkinson Disease Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Parkinson Disease Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Parkinson Disease Market by Drug Class
3.3.1: Carbidopa-Levodopa
3.3.2: Dopamine Agonists
3.3.3: MAO-B Inhibitors
3.3.4: COMT Inhibitors
3.3.5: Anticholinergics
3.3.6: Others

3.4: Global Parkinson Disease Market by Distribution Channel
3.4.1: Hospital Pharmacy
3.4.2: Retail Pharmacy
3.4.3: Online Pharmacy






4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Parkinson Disease Market by Region
4.2: North American Parkinson Disease Market
4.2.2: North American Parkinson Disease Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy


4.3: European Parkinson Disease Market
4.3.1: European Parkinson Disease Market by Drug Class: Carbidopa-Levodopa, Dopamine Agonists, MAO-B Inhibitors, COMT Inhibitors, Anticholinergics, and Others
4.3.2: European Parkinson Disease Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy


4.4: APAC Parkinson Disease Market
4.4.1: APAC Parkinson Disease Market by Drug Class: Carbidopa-Levodopa, Dopamine Agonists, MAO-B Inhibitors, COMT Inhibitors, Anticholinergics, and Others
4.4.2: APAC Parkinson Disease Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy


4.5: ROW Parkinson Disease Market
4.5.1: ROW Parkinson Disease Market by Drug Class: Carbidopa-Levodopa, Dopamine Agonists, MAO-B Inhibitors, COMT Inhibitors, Anticholinergics, and Others
4.5.2: ROW Parkinson Disease Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Parkinson Disease Market by Drug Class
6.1.2: Growth Opportunities for the Global Parkinson Disease Market by Distribution Channel
6.1.3: Growth Opportunities for the Global Parkinson Disease Market by Region


6.2: Emerging Trends in the Global Parkinson Disease Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Parkinson Disease Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Parkinson Disease Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Cerevel Therapeutics
7.2: Novartis
7.3: Teva Pharmaceutical Industries
7.4: Merck & Co.
7.5: GlaxoSmithKline
7.6: AbbVie
7.7: H. Lundbeck